AAOpt 2023: The perfect presbyopic patient

News
Article

Post-hoc data helps shine light on better understanding what patient demographics are best suited for presbyopia drops.

Jade Coats, OD, caught up with Optometry Times®' during the 2023 American Academy of Optometry meeting in New Orleans to share a brief overview of a presbyopia poster she was presenting.

Editor's note: This transcript has been lightly edited for clarity.

Jade Coats, OD:

My name is Jade Coats. I'm an optometrist practicing in Northwest Arkansas at McDonald Eye Associates.

At Academy here in New Orleans this week I plan to present on behalf of Orasis regarding some really interesting poster information, some post-hoc data that actually is really helping us understand better the perfect demographics for the presbyopia drops.

Some key takeaways are that surprisingly, but also not surprisingly, there might be a perfect person. And clinically speaking, we know that evaluating the best-corrected distance near acuity is really going to be an important factor in determining who's the best patient for this presbyopia drop.

The next step for this research would be to launch the product and obviously to get our hands on it, get it into the clinics, get it into the patient's hands and have them try it.

Presbyopia has been around; it's not going anywhere. It affects every human blessed to have enough birthdays and so now we have an alternative treatment option and it's just really exciting times but that has to do with pharmaceuticals.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Steven Greenstein, MD, one of the cochairs of the Collaborative Care Symposium gave some insight into the upcoming conference and what attendees can expect.
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Karl Stonecipher ASCRS 2025
© 2025 MJH Life Sciences

All rights reserved.